Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06565442 · ClinicalTrials.gov registry record
Feasibility of Using NeuraSignal Transcranial Doppler Robot
A clinical trial, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- 20
- Enrollment target
NCT06565442: Clinical Trial study, sponsored by University of Alabama at Birmingham.
NCT06565442 is a clinical trial that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06565442 has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Primary Outcome
Cerebral autoregulatory curve generation using the NeuraSignal transcranial doppler robot correlated with arterial blood pressure measurements in neuro ICU patients admitted for blood pressure management after spinal surgery
Interventions
- DEVICE NeuraSignal transcranial doppler robot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-12-15 |
What is known before NCT06565442 opens enrollment
NCT06565442 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which NeuraSignal transcranial doppler robot is the first listed.
NCT06565442 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06565442 about?
NCT06565442 is a clinical study titled "Feasibility of Using NeuraSignal Transcranial Doppler Robot". The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
What is the current status of trial NCT06565442?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-06-15. Estimated completion is 2027-12-15.
What interventions are being tested in trial NCT06565442?
The interventions under investigation include: NeuraSignal transcranial doppler robot (DEVICE).
Who is sponsoring clinical trial NCT06565442?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI